Analyst Ratings for [RCM] R1 RCM Inc.

8/8/24	Downgrades	Overweight Eq-Weight	X
RCM R1 RCM Morgan Stanley
8/1/24	Downgrades	Buy Hold	X
RCM R1 RCM Jefferies
8/1/24	Downgrades	Outperform Mkt Perform	X
RCM R1 RCM Leerink Partners
8/1/24	Downgrades	Overweight Eq-Weight	X
RCM R1 RCM Stephens
4/10/24	Downgrades	Overweight Sec Weight	X
RCM R1 RCM KeyBanc Capital Markets
3/20/24	Upgrades	Neutral Buy	X
RCM R1 RCM Citigroup
$16
2/26/24	Initiated	Outperform	X
RCM R1 RCM Leerink Partners
$14
1/3/24	Initiated	Overweight	X
RCM R1 RCM Barclays
$14
12/15/23	Upgrades	Eq-Weight Overweight	X
RCM R1 RCM Morgan Stanley
$17.50 $17
12/13/23	Downgrades	Overweight Neutral	X
RCM R1 RCM JP Morgan
$20 $11
10/19/23	Upgrades	Hold Buy	X
RCM R1 RCM Truist
$18
9/22/23	Initiated	Buy	X
RCM R1 RCM Citigroup
$20
8/15/23	Initiated	Overweight	X
RCM R1 RCM Cantor Fitzgerald
$20
4/12/23	Initiated	Overweight	X
RCM R1 RCM Stephens
$18
4/11/23	Initiated	Outperform	X
RCM R1 RCM Robert W. Baird
$18
2/2/23	Downgrades	Buy Hold	X
RCM R1 RCM Truist
$15
1/5/23	Initiated	Buy	X
RCM R1 RCM Canaccord Genuity
$14
12/7/22	Upgrades	Neutral Buy	X
RCM R1 RCM Guggenheim
$15
12/6/22	Initiated	Equal-Weight	X
RCM R1 RCM Morgan Stanley
$11
10/24/22	Initiated	Outperform	X
RCM R1 RCM Evercore ISI
$25
9/16/22	Initiated	Overweight	X
RCM R1 RCM KeyBanc Capital Markets
$30
9/7/22	Initiated	Buy	X
RCM R1 RCM Truist
$29
8/1/22	Resumed	Overweight	X
RCM R1 RCM JP Morgan
$28 $33
6/29/22	Resumed	Overweight	X
RCM R1 RCM Barclays
$29
4/14/22	Initiated	Neutral	X
RCM R1 RCM Guggenheim
2/9/22	Initiated	Buy	X
RCM R1 RCM Deutsche Bank
$30
12/2/21	Initiated	Buy	X
RCM R1 RCM Jefferies
$28
10/14/21	Initiated	Overweight	X
RCM R1 RCM JP Morgan
$27
7/22/21	Initiated	Buy	X
RCM R1 RCM BofA Securities
$27
6/2/21	Initiated	Outperform	X
RCM R1 RCM Robert W. Baird
$30
1/22/19	Initiated	Overweight	X
RCM R1 RCM KeyBanc Capital Mkts
$10
12/10/18	Initiated	Buy	X
RCM R1 RCM Citigroup
$20
9/4/18	Initiated	Buy	X
RCM R1 RCM Chardan Capital Markets
$17
4/9/18	Upgrades	Neutral Outperform	X
RCM R1 RCM Robert W. Baird

RCM R1 RCM Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

R1 RCM Inc., formerly Accretive Health, Inc., is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship. The Company's PAS offering assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes. The Company also provides customers with retrospective appeal management service support for both governmental and commercial payers. Its physicians conduct detailed retrospective reviews of medical records to identify medical necessity for hospital services and the required documentation to support an appeal.